FDA: New York dietary supplement manufacturer enters into consent decree

The U.S. Food and Drug Administration has announced that Howard Sousa, doing business as the Artery Health Institute LLC, and DeSousa LLC, in New York, N. an evaluation of ivermectin in the treatment of sarcoptic mange in dogs. Y., has signed a consent decree of permanent injunction. medicine ivermectin The consent decree prohibits Sousa from distributing products with claims in the labeling to cure, treat, mitigate or prevent diseases. ivermectina pode comprar sem receita